Imidazonaphthyridines And Their Use In Inducing Cytokine Biosynthesis

Details for Australian Patent Application No. 2002300985 (hide)

Owner Minnesota Mining and Manufacturing Company

Inventors Mickelson, John W.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002300985

Parent 19123

Filing date 4 September 2002

Wipo publication date 20 February 2003

Acceptance publication date 2 December 2004

International Classifications

C07D 471/14 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 031/505 - Pyrimidines

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-B-2002300985

5 August 2004 Amendment Made

  The nature of the amendment is: Amend the name of the inventors from Gerster, John F. and Lingstrom, Kyle J. to Mickelson, John W.

2 December 2004 Application Accepted

  Published as AU-B-2002300985

7 April 2005 Standard Patent Sealed

5 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300986-Renal Cell Carcinoma-Antigen G250-derived Peptides that elicit both CD4+ and CD8+T-cell Responses

2002300984-Imidazonaphthyridines and their use in inducing cytokine biosynthesis